Stay updated on ODM-208 Safety & PK in Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the ODM-208 Safety & PK in Metastatic CRPC Clinical Trial page.

Latest updates to the ODM-208 Safety & PK in Metastatic CRPC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new site revision entry 'Revision: v3.3.3' was added to the history and the footer no longer displays 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedRevision v3.3.2 was added and revision v3.2.0 was removed from the record history. This reflects a minor administrative update to the page.SummaryDifference0.1%

- Check54 days agoChange DetectedDeleted a government funding-related notice about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedNew screenshot shows updates to the record history entries, with no changes to core study details such as interventions, outcomes, or eligibility; these appear to be administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference11%

- Check104 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to ODM-208 Safety & PK in Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ODM-208 Safety & PK in Metastatic CRPC Clinical Trial page.